2024 Annual Meeting | C113 - Ictus (Stroke)
Program Materials Program Evaluations
07:00 AM - 07:25 AM MDT | Speaker |
Trombectomía mecánica: Selección de pacientes más allá de las guías actuales
Alberto Maud, MD |
07:25 AM - 07:50 AM MDT | Speaker |
Optimización de la terapia antitrombótica después de un ictus isquémico agudo
Victor J. Del Brutto, MD |
07:50 AM - 08:15 AM MDT | Speaker |
Valoración del paciente con ictus embólico de origen no determinado y cierre del foramen oval persistente
Karen D. Orjuela, MD, FAAN |
08:15 AM - 08:40 AM MDT | Speaker |
Trombolisis intravenosa: opciones de farmacos y ventanas de tratamiento
Enrique C. Leira, MD, MS, FAAN |
08:40 AM - 09:00 AM MDT | Q&A |
Optimización del manejo del ictus isquémico agudo
Victor J. Del Brutto, MD, Enrique C. Leira, MD, MS, FAAN, Alberto Maud, MD, Karen D. Orjuela, MD, FAAN |
Victor J. Del Brutto, MD | The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association. The institution of Dr. Del Brutto has received research support from American Heart Association. |
Enrique C. Leira, MD, MS, FAAN | Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS. |
Alberto Maud, MD | Dr. Maud has nothing to disclose. |
Karen D. Orjuela, MD, FAAN | The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation. |